Common drug tested to save blood during major operations
NCT ID NCT04803747
Summary
This large, completed study tested whether a hospital policy of giving the drug tranexamic acid (TXA) to patients having major non-heart surgery would safely reduce the need for blood transfusions. Over 8,400 patients across many hospitals were involved. The trial aimed to see if TXA lowered transfusion rates without increasing the risk of dangerous blood clots after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR NON-CARDIAC SURGERIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Grace Hospital
Winnipeg, Manitoba, R3J 3M7, Canada
-
Health Sciences North Research Institute
Greater Sudbury, Ontario, P3E 5J1, Canada
-
Humber River Hospital
Toronto, Ontario, M3M 0B2, Canada
-
Hôpital Montfort
Ottawa, Ontario, K1K 0T2, Canada
-
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7, Canada
-
London Health Sciences Centre
London, Ontario, N6A 5A5, Canada
-
Ottawa Hospital Research Institute- Civic Campus
Ottawa, Ontario, K1Y 4E9, Canada
-
Ottawa Hospital Research Institute- General Campus
Ottawa, Ontario, K1H8L6, Canada
-
St. Boniface Hospital
Winnipeg, Manitoba, R2H 2A6, Canada
-
University of Manitoba- HSC Campus
Winnipeg, Manitoba, R3E 0W2, Canada
Conditions
Explore the condition pages connected to this study.